Min Xie
- Cancer Research top 1%
- NF-κB Signaling Pathways 8
- Molecular Biology top 1%
- CRISPR and Genetic Engineering 10
- Pluripotent Stem Cells Research 10
- Ubiquitin and proteasome pathways 8
- Histone Deacetylase Inhibitors Research 8
- Mitochondrial Function and Pathology 7
- Aging top 2%
- Physiology top 1%
-
- Autophagy in Disease and Therapy 12
-
- Advanced ceramic materials synthesis 7
- Co-authors
- Joseph A. HillMichael SchneiderJana BurchfieldSheng DingTianhua MaDaolin TangLi CaoZhanhui Ou
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Min Xie
115 papers receiving 7.6k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Cancer Research 1.5k
- Molecular Biology 4.8k
- Aging 99
- Cardiology and Cardiovascular Medicine 1.2k
- Physiology 197
Countries citing papers authored by Min Xie
This map shows the geographic impact of Min Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Xie more than expected).
Fields of papers citing papers by Min Xie
This network shows the impact of papers produced by Min Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Xie. The network helps show where Min Xie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Min Xie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 10 | |
| 8 | 2022 | 5 | |
| 9 | 2022 | 17 | |
| 10 | 2021 | 17 | |
| 11 | 2020 | 26 | |
| 12 | 2019 | 20 | |
| 13 | 2017 | 141 | |
| 14 | 2016 | 289 | |
| 15 | 2016 | 61 | |
| 16 | Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidificationbreakdown → | 2016 | 359 |
| 17 | 2016 | 16 | |
| 18 | Effect of chemotherapy combined with traditional Chinese medicine on the expression of TMSG- 1 in transplantation tumor of human breast cancer in nude mice | 2013 | 1 |
| 19 | 2011 | 81 | |
| 20 | 2007 | 50 |
About Min Xie
Min Xie is a scholar working on Ceramics and Composites, Physiology and Molecular Biology, having authored 125 papers that have together received 7.7k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (12 papers), CRISPR and Genetic Engineering (10 papers), Pluripotent Stem Cells Research (10 papers), Ubiquitin and proteasome pathways (8 papers), Histone Deacetylase Inhibitors Research (8 papers), NF-κB Signaling Pathways (8 papers), Advanced ceramic materials synthesis (7 papers) and Mitochondrial Function and Pathology (7 papers). The work is most often cited by research in Cancer Research (1.5k citations), Molecular Biology (4.8k citations) and Aging (99 citations). Min Xie has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Joseph A. Hill, Michael Schneider, Jana Burchfield, Sheng Ding, Tianhua Ma, Sheng Ding, Daolin Tang, Li Cao, Zhanhui Ou and Xiaofang Sun.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.